In G3 breast cancer, rearrangement of BCL6 showed a frequency of 4.9% ± SE 0.45%, vs a significant decrease to 1.62% ± SE 0.15% and 1.40% ± SE 0.29% in G1/G2 breast cancer and in control respectively (Figure 1D). This evidence concerns the gene BCL6 and breast cancer.